Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies.
- DOI
- 10.1007/s13555-025-01639-0
- Published
- 2026 Mar
- Container
- Dermatology and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13555-025-01639-0,
title = {Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies.},
author = {Blauvelt A and Kircik L and Simpson EL and Lio P and Eichenfield LF and Prajapati VH and Grewal P and Lynde C and Hong HC and Sturm D and Kallender H and Ren H and Paranagama D and Wong GKW and Geng B},
year = {2026},
journal = {Dermatology and therapy},
doi = {10.1007/s13555-025-01639-0},
url = {https://doi.org/10.1007/s13555-025-01639-0}
}RIS
TY - JOUR TI - Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies. AU - Blauvelt A AU - Kircik L AU - Simpson EL AU - Lio P AU - Eichenfield LF AU - Prajapati VH AU - Grewal P AU - Lynde C AU - Hong HC AU - Sturm D AU - Kallender H AU - Ren H AU - Paranagama D AU - Wong GKW AU - Geng B PY - 2026 JO - Dermatology and therapy DO - 10.1007/s13555-025-01639-0 UR - https://doi.org/10.1007/s13555-025-01639-0 ER -
APA
A, B., L, K., EL, S., P, L., LF, E., VH, P., P, G., C, L., HC, H., D, S., H, K., H, R., D, P., GKW, W., & B, G. (2026). Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies.. Dermatology and therapy. https://doi.org/10.1007/s13555-025-01639-0
Source records
- pubmed · retrieved 2026-09-26T14:29:26.836Z